SCHEMBL16057423

SCHEMBL16057423

Cc1c(-c2ccc(-c3ccncc3)cc2)ccnc1OC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNC P24863 2/20 0.39
▸ CDK8 P49336 2/20 0.39
▸ PIK3CA P42336 1/20 0.39
▸ CYP46A1 Q9Y6A2 1/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NLRP1 Q9C000 1/20 0.36
▸ IKBKB O14920 1/20 0.36
▸ CHEK2 O96017 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ CSNK1A1 P48729 1/20 0.36
▸ CSNK1D P48730 1/20 0.36
▸ CLK2 P49760 1/20 0.36
▸ CSNK1G1 Q9HCP0 1/20 0.36
▸ PARP10 Q53GL7 1/20 0.35
▸ PARP11 Q9NR21 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14975894 0.91 PORCN (0.40) PIK3CACYP3A4ALDH1A1MEN1KMT2A
SCHEMBL16056911 0.87 ACACB (0.35) CCNCCDK8ALDH1A1MEN1KMT2A
SCHEMBL16058416 0.86 MKNK1 (0.48) PIK3CACYP3A4CHEK2PORCNCYP2D6
SCHEMBL16057936 0.84 KIF11 (0.40) ALDH1A1KDM4EKMT2A
SCHEMBL16057947 0.84 SLC22A12 (0.39) ALDH1A1MEN1KMT2AACACBSLC22A12
SCHEMBL16056981 0.84 SLC6A7 (0.41) ALDH1A1KDM4EEPHX1
SCHEMBL16057338 0.84 KMO (0.44) PIK3CACYP3A4MEN1KMT2APORCN
SCHEMBL16057040 0.83 RAB9A (0.44) ALDH1A1MEN1KMT2A
SCHEMBL16058150 0.82 PDE10A (0.40) ALDH1A1KDM4EKMT2AACACBHPGD
SCHEMBL16058685 0.82 LMNA (0.39) ALDH1A1MEN1KMT2AHPGDEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828338-B2 Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-28 — — US disclosed
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-03-10 — — US disclosed
WO-2014144836-A2 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS NAAA, FAAH, FAAH2 CCNC 3386/4885CDK8 1112/4885PIK3CA 1020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback